Galapagos NV is a biotechnology company. The Company's operating segment consists of Research and Development and Services. Research and Development segment is engaged in the discovery and development of small molecules. Services segment offers drug discovery products and services. Its products include GLPG0634 for the treatment of rheumatoid arthritis and other inflammatory diseases, GLPG1205/GLPG1690 for treating inflammatory bowel disease, GSK2586184 for the treatment of chronic immuno-inflammatory diseases and GLPG0974, to prevent free fatty acid-induced activation and migration of neutrophils which are in different clinical trial. Galapagos NV is headquartered in Mechelen, Belgium.
Address Details
Address: GEN DE WITTELAAN L11 A3
City: MECHELEN
State: C9
Country: BEL
Zip Code: 2800
Contact Details
321-534-2900
This weeks newsletter: 🚀 Retail Access to SpaceX, BlackBerry’s Big Moves, Trends to Watch 📈